Selecta Biosciences

$3.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (+5.19%) As of 6:27 PM UTC today

Why Robinhood?

You can buy or sell SELB and other stocks, options, and ETFs commission-free!

About SELB

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. It produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation.

CEO
Carsten Brunn
Employees
43
Headquarters
Watertown, Massachusetts
Founded
2007
Market Cap
446.26M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
771.39K
High Today
$3.85
Low Today
$3.58
Open Price
$3.61
Volume
293.63K
52 Week High
$5.70
52 Week Low
$1.47

SELB Earnings

-$0.33
-$0.22
-$0.11
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market

You May Also Like

JPN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure